HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

about

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

Item

http://www.wikidata.org/entity/Q48360515

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@en

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@nl

type

Item

label

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@en

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@nl

prefLabel

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@en

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.

@nl

P1476

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17

@en

P2093

Kaoru Hamada

http://www.w3.org/2001/XMLSchema#string

Motonobu Nakamura

http://www.w3.org/2001/XMLSchema#string

Ryosuke Hino

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.

Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.

Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.

P304

e154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJD.12701

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu Sawada

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28736838

http://www.w3.org/2001/XMLSchema#string

P921

Human T-lymphotropic virus 1